SCHEDULE 13G/A
Statement of Beneficial Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0000935836-26-000590
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| EcoR1 Capital, LLC | 3,028,116 | 2.9% |
| Oleg Nodelman | 3,028,116 | 2.9% |
| EcoR1 Capital Fund Qualified, L.P. | 2,885,435 | 2.8% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…